Competitive Bidding of Drugs Plan Disapproved

Why This Topic Matters

These payment changes can affect how physician practices acquire, bill for, and are reimbursed for drugs, making the topic important for practice finance, patient access, and Medicare compliance planning.

Article Sections

1. Medicare drug payment changes and practice concerns

   This section summarizes the proposed direction of Medicare drug reimbursement and the concerns raised by physician groups. It focuses on how the policy could affect practices and patients.

2. ASP payment approach and CMS comments

   This section discusses the Average Sales Price framework and CMS remarks about how the policy would be administered. It also touches on timing and implementation questions raised during the meeting.

3. What MMA says about ‘competitive bidding’

   This section outlines the broad Medicare reform law framework related to future drug vendor competition. It presents general features of the program structure and vendor requirements.